Actio Biosciences
1 known investors
Actio is a precision medicine company that uses human genetics and drug discovery to develop treatments targeting shared biology between rare and common diseases. It starts with Mendelian (single-gene) rare diseases to identify and de-risk drug targets, then aims to expand therapies to more prevalent indications.